Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Sanofi stock in Canada | $45.8
Own Sanofi shares in just a few minutes.
Sanofi (SNY) is a leading drug manufacturers-general business based in the US. It opened the day at $51.48 after a previous close of $51.01. During the day the price has varied from a low of $51.44 to a high of $51.935. The latest price was $51.82 (25 minute delay). Sanofi is listed on the NASDAQ and employs 99,412 staff. All prices are listed in US Dollars.
How to buy shares in Sanofi
- Choose a platform. If you're a beginner, our share-dealing table below can help you choose.
- Open your account. You'll need your ID, bank details and national insurance number.
- Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
- Search the platform for stock code: SNY in this case.
- Research Sanofi shares. The platform should provide the latest information available.
- Buy your Sanofi shares. It's that simple.
What's in this guide?
- Can I buy shares in Sanofi?
- Has coronavirus impacted Sanofi shares?
- Sanofi shares summary
- Compare share dealing platforms
- Is Sanofi stock a buy or sell?
- Sanofi performance over time
- Can I short Sanofi shares?
- Are Sanofi shares over-valued?
- Sanofi's financials
- How volatile are Sanofi shares?
- Does Sanofi pay a dividend?
- Have Sanofi shares ever split?
- Other common questions
How has Coronavirus impacted Sanofi's share price?
Since the stock market crash in March caused by coronavirus, Sanofi's share price has had significant negative movement.
Its last market close was $45.8, which is 9.93% down on its pre-crash value of $50.85 and 21.74% up on the lowest point reached during the March crash when the shares fell as low as $37.62.
If you had bought $1,000 worth of Sanofi shares at the start of February 2020, those shares would have been worth $797.24 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $946.69.
Sanofi share priceUse our graph to track the performance of SNY stocks over time.
Sanofi shares at a glance
|52-week range||$44.76 - $55|
|50-day moving average||$50.4076|
|200-day moving average||$48.9392|
|Wall St. target price||$63.88|
|Dividend yield||$3.2 (6.07%)|
|Earnings per share (TTM)||$5.8185|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy Sanofi stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Sanofi price performance over time
|1 week (2021-04-30)||-1.05%|
|1 month (2021-04-08)||2.84%|
|3 months (2021-02-08)||6.56%|
|6 months (2020-11-06)||5.22%|
|1 year (2020-05-08)||7.78%|
|2 years (2019-05-08)||25.99%|
|3 years (2018-05-08)||34.04%|
|5 years (2016-05-06)||33.04%|
Is Sanofi under- or over-valued?
Valuing Sanofi stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Sanofi's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Sanofi's P/E ratio
Sanofi's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 9x. In other words, Sanofi shares trade at around 9x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Sanofi's PEG ratio
Sanofi's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 3.9996. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Sanofi's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Sanofi's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$10.6 billion.
The EBITDA is a measure of a Sanofi's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||USD$36.9 billion|
|Operating margin TTM||21.1%|
|Gross profit TTM||USD$25.3 billion|
|Return on assets TTM||4.19%|
|Return on equity TTM||20.01%|
|Market capitalisation||USD$131.6 billion|
TTM: trailing 12 months
How to short and sell Sanofi shares
- Create a CFD or spread betting account.
- Search for the stock code. E.g. "SNY.US"
- Choose your position size.
- Select "sell" rather than "buy".
- Confirm your position and keep tabs on it. You may wish to set limits on your position.
There are currently 5.3 million Sanofi shares held short by investors – that's known as Sanofi's "short interest". This figure is 9.2% up from 4.9 million last month.
There are a few different ways that this level of interest in shorting Sanofi shares can be evaluated.
Sanofi's "short interest ratio" (SIR)
Sanofi's "short interest ratio" (SIR) is the quantity of Sanofi shares currently shorted divided by the average quantity of Sanofi shares traded daily (recently around 1.2 million). Sanofi's SIR currently stands at 4.47. In other words for every 100,000 Sanofi shares traded daily on the market, roughly 4470 shares are currently held short.
However Sanofi's short interest can also be evaluated against the total number of Sanofi shares, or, against the total number of tradable Sanofi shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Sanofi's short interest could be expressed as 0% of the outstanding shares (for every 100,000 Sanofi shares in existence, roughly 0 shares are currently held short) or 0% of the tradable shares (for every 100,000 tradable Sanofi shares, roughly 0 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Sanofi.
Find out more about how you can short Sanofi stock.
Sanofi share dividends
Dividend payout ratio: 53.97% of net profits
Recently Sanofi has paid out, on average, around 53.97% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 3.64% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Sanofi shareholders could enjoy a 3.64% return on their shares, in the form of dividend payments. In Sanofi's case, that would currently equate to about $3.2 per share.
Sanofi's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
Sanofi's most recent dividend payout was on 25 May 2021. The latest dividend was paid out to all shareholders who bought their shares by 2 May 2021 (the "ex-dividend date").
Have Sanofi's shares ever split?
Sanofi's shares were split on a 5:1 basis on 29 September 2013. So if you had owned 1 share the day before before the split, the next day you'd have owned 5 shares. This wouldn't directly have changed the overall worth of your Sanofi shares – just the quantity. However, indirectly, the new 80% lower share price could have impacted the market appetite for Sanofi shares which in turn could have impacted Sanofi's share price.
Sanofi share price volatility
Over the last 12 months, Sanofi's shares have ranged in value from as little as $44.76 up to $55. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Sanofi's is 0.3898. This would suggest that Sanofi's shares are less volatile than average (for this exchange).
Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antibodies; products for multiple sclerosis, neurology, other inflammatory diseases, immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes; and cardiovascular and established prescription products. It also supplies poliomyelitis, pertussis, and hib pediatric vaccines; and influenza, adult booster, meningitis, and travel and endemic vaccines. In addition, the company offers allergy, cough and cold, pain, digestive, and nutritional products; and other products, such as daily body lotions, anti-itch products, moisturizing and soothing lotions, and body and foot creams, as well as powders for eczema. It also has various pharmaceutical products and vaccines in development stage. Sanofi has collaboration agreement with GlaxoSmithKline to develop a recombinant Covid-19 vaccine. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France.
Frequently asked questions
More guides on Finder
How to buy Bragg Gaming Group stock in Canada
Steps to owning and managing Bragg Gaming Group Inc. (BRAG) stocks, with 24-hour and historical pricing before you buy.
How to buy Waterloo Brewing stock in Canada
Steps to owning and managing Waterloo Brewing (WBR) stocks, with 24-hour and historical pricing before you buy.
How to buy PyroGenesis Canada stock in Canada
Steps to owning and managing PyroGenesis Canada (PYR) stock, with 24-hour and historical pricing before you buy.
How to buy GoGold Resources stock in Canada
Steps to owning and managing GoGold Resources (GGD), with 24-hour and historical pricing before you buy.
How to buy Bio-Rad Laboratories stock in Canada
Steps to owning and managing BIO, with 24-hour and historical pricing before you buy.
How to buy Ares Management Corporation stock in Canada
Steps to owning and managing ARES, with 24-hour and historical pricing before you buy.
How to buy Brookfield Infrastructure Partners L-P stock in Canada
Steps to owning and managing BIP, with 24-hour and historical pricing before you buy.
How to buy Logitech International S-A stock in Canada
Steps to owning and managing LOGI, with 24-hour and historical pricing before you buy.
How to buy PerkinElmer stock in Canada
Steps to owning and managing PKI, with 24-hour and historical pricing before you buy.
How to buy Ubiquiti stock in Canada
Steps to owning and managing UI, with 24-hour and historical pricing before you buy.